Notice of Intent to Award Sole Source - Extension of Mammography Quality Standards Act (MQSA) Certification and Hotline Inquiries Contract
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA) intends to award a Sole Source 6-month contract extension to Impyrian LLC for the Mammography Quality Standards Act (MQSA) Certification and Hotline Inquiries Program. This notice is for informational purposes, but other firms can submit capability statements by April 3, 2026, 5:00 pm (EDT).
Scope of Work
The primary objectives of this requirement include:
- Operating and maintaining the current system for issuing federal certificates to mammography facilities under MQSA.
- Operating and maintaining the current MQSA hotline certification inquiries system, including real-time responses and record-keeping for written, telephone, email, and fax inquiries.
- Operating and maintaining the current database system for scanning mammography certification letters mailed to facilities.
Contract & Timeline
- Type: Sole Source (Notice of Intent to Award)
- Duration: 6-month contract extension
- NAICS: 541511 – Custom Computer Programming Services
- Response Due: April 3, 2026, 5:00 pm (EDT)
- Published: March 30, 2026
Evaluation
This notice is not a request for competitive quotes. However, other firms desiring consideration must fully identify their interest and capability by submitting a capability statement. The government will review responses to determine if requirements can be met, with the final decision to not compete remaining at the government's discretion.
Additional Notes
The authority for this sole source action is FAR Part 6 (6.103-1, Only One Responsible Source), with the extension processed under FAR Part 52.217-8. Responses should be sent to Thomas Lawson at Thomas.lawson@fda.hhs.gov.